July 17 Sucampo Pharmaceuticals Inc. on Tuesday set its initial public offering of 3.75 million Class A common shares at an estimated price of $14 to $16 per share.
The pharmaceutical company plans to list on the Nasdaq under the symbol "SCMP," it said in a filing with the U.S. Securities and Exchange Commission.
Sucampo said it expects to raise net proceeds of about $38.6 million and plans to use the proceeds to fund its clinical trials.
The company is focused on developing drugs based on prostones, a class of compounds derived from functional fatty acids that occur naturally in the human body.
In January 2006, its first product, Amitiza, received marketing approval from U.S regulators for the treatment of chronic idiopathic constipation in adults. (Reporting by Jennifer Robin Raj in Bangalore)
AT&T reaches deal to buy Time Warner for more than $80 billion -WSJ
Oct 22 AT&T Inc reached a deal to buy media company Time Warner Inc for more than $80 billion, The Wall Street Journal reported on Saturday.
Trump vows to weaken U.S. media 'power structure' if elected
GETTSYBURG, Pa. , Oct 22 U.S. Republican presidential candidate Donald Trump promised on Saturday to foil a proposed deal for AT&T Inc to buy Time Warner Inc if he wins the Nov. 8 election, arguing it was an example of a "power structure" rigged against both him and voters.